Lh. Hansen et al., THE GLY40SER MUTATION IN THE HUMAN GLUCAGON RECEPTOR GENE ASSOCIATED WITH NIDDM RESULTS IN A RECEPTOR WITH REDUCED SENSITIVITY TO GLUCAGON, Diabetes, 45(6), 1996, pp. 725-730
Citations number
21
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
The pancreatic islet hormone, glucagon, stimulates hepatic glucose pro
duction and has also been shown to potentiate glucose-induced insulin
secretion, Because glucagon is a key regulator of glucose homeostasis,
its receptor, which mediates the actions of glucagon, was considered
a candidate gene involved in the pathogenesis of NIDDM, We have previo
usly reported that a single heterozygous missense mutation in exon 2 o
f the glucagon receptor gene, which changes a glycine to a serine (Gly
40Ser), is associated with NIDDM in a French population, In the presen
t study, the signaling properties of this mutant receptor were examine
d in baby hamster kidney cells and rat insulinoma cells (RIN-5AH) stab
ly transfected with either the wild type or Gly40Ser mutant human gluc
agon receptor cDNAs, Competition assays using I-125-labeled glucagon w
ere performed, and in both cell types, the Gly40Ser mutant receptor wa
s found to bind glucagon with an approximately threefold lower affinit
y compared with the wild type receptor, In both cell. types, tile prod
uction of cAMP in response to glucagon was decreased in cells expressi
ng the mutant receptor compared with those expressing the wild type, F
inally, glucagon-stimulated insulin secretion by RIN cells expressing
the mutant receptor was decreased such that the dose-response curve wa
s shifted to the right in comparison to that obtained with cells expre
ssing the wild type receptor. These results indicate that this single-
point mutation located in the extracellular region of the glucagon rec
eptor decreases the sensitivity of target tissues to glucagon.